DOV PHARMACEUTICAL INC (DOVP) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 90 transactions totaling $11.3M, demonstrating a bearish sentiment with -$11.0M in net insider flow. The most recent transaction on Nov 19, 2008 involved a purchase of 772,327 shares valued at $0.
No significant insider buying has been recorded for DOVP in the recent period.
No significant insider selling has been recorded for DOVP in the recent period.
Based on recent SEC filings, insider sentiment for DOVP is bearish with an Insider Alignment Score of 1/100 and a net flow of -$11.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at DOV PHARMACEUTICAL INC (DOVP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading DOVP stock, having executed 90 transactions in the past 90 days. The most active insider is Pharmaceutical Inc Dov (Executive), who has made 61 transactions totaling $8.7M.
Get notified when executives and directors at DOVP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 19, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 772,327 | $N/A | $0 | |
| Sep 30, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 125,000 | $0.04 | $5.0K | |
| Sep 30, 2008 | S. Zakrzewski Joseph | Executive | Award | 125,000 | $0.04 | $5.0K | |
| Sep 15, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 16,500 | $0.04 | $660 | |
| Sep 12, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 10,000 | $0.04 | $400 | |
| Sep 9, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 1,330 | $0.04 | $53 | |
| Sep 8, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 51,500 | $0.04 | $2.1K | |
| Sep 5, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 7,051 | $0.04 | $282 | |
| Aug 27, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 200,000 | $0.04 | $8.0K | |
| Jul 16, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 10,495 | $0.04 | $420 | |
| Jun 30, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 75,826 | $0.04 | $3.0K | |
| Jun 27, 2008 | S. Zakrzewski Joseph | Executive | Purchase | 1,000 | $0.04 | $40 | |
| Apr 3, 2008 | Inc Dov Pharmaceutical | Executive | Purchase | 100,000 | $0.05 | $5.0K | |
| Jan 9, 2008 | Inc Dov Pharmaceutical | Executive | Purchase | 13,800 | $0.07 | $966 | |
| Sep 7, 2007 | Inc Dov Pharmaceutical | Executive | Purchase | 25,000 | $0.20 | $5.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 54 | $11.1M | 94.0% |
Conversion(C) | 12 | $542.1K | 4.6% |
Purchase(P) | 17 | $162.2K | 1.4% |
Award(A) | 6 | $5.0K | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at DOV PHARMACEUTICAL INC has increased, with 12 insiders executing 90 transactions across all time. Total sales of $11.1M significantly outpace purchases of $162.2K, resulting in a net outflow of $11.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.